Literature DB >> 2433539

Modulation of cAMP: mechanism for positive inotropic action.

D B Evans.   

Abstract

Modulation of intracellular cAMP in cardiac cells results in a positive inotropic effect. This effect is achieved by increasing intracellular cAMP, via a variety of ways, which leads to the phosphorylation of proteins in the sarcolemma, sarcoplasmic reticulum, and contractile filaments. This phosphorylation alters calcium metabolism in the cell to effect an increase in the influx of extracellular calcium, an increase in sarcoplasmic reticulum uptake of calcium, and an altered sensitivity of the contractile proteins to calcium. These changes in cellular metabolism of calcium effect an increase in cardiac contractility which is associated with an increase in rate of both contraction and relaxation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2433539

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  11 in total

Review 1.  Regulating cellular cyclic adenosine monophosphate: "Sources," "sinks," and now, "tunable valves".

Authors:  Michael Getz; Padmini Rangamani; Pradipta Ghosh
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2020-04-23

Review 2.  Protein phosphorylation and compartments of cyclic AMP in the control of cardiac contraction.

Authors:  K J Murray; M L Reeves; P J England
Journal:  Mol Cell Biochem       Date:  1989-09-07       Impact factor: 3.396

3.  Modulation of cAMP level by tedisamil in guinea pig heart.

Authors:  N Tribulova; T Ravingerova; L Okruhlicova; I Gabauer; M Fickova; D Pancza; J Slezak; M Manoach
Journal:  Mol Cell Biochem       Date:  2000-07       Impact factor: 3.396

4.  The effects of siguazodan, a selective phosphodiesterase inhibitor, on human platelet function.

Authors:  K J Murray; P J England; T J Hallam; J Maguire; K Moores; M L Reeves; A W Simpson; T J Rink
Journal:  Br J Pharmacol       Date:  1990-03       Impact factor: 8.739

5.  Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure.

Authors:  T Ishimitsu; T Nishikimi; Y Saito; K Kitamura; T Eto; K Kangawa; H Matsuo; T Omae; H Matsuoka
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

6.  Cardiotonic actions of selective phosphodiesterase inhibitors in rat isolated ventricular cardiomyocytes.

Authors:  E J Kelso; B J McDermott; B Silke
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

Review 7.  Inotropic support of the critically ill patient. A review of the agents.

Authors:  P J Kulka; M Tryba
Journal:  Drugs       Date:  1993-05       Impact factor: 9.546

8.  Effect of adrenergic and muscarinic cholinergic agonists on atrial natriuretic peptide secretion by isolated rat atria. Potential role of the autonomic nervous system in modulating atrial natriuretic peptide secretion.

Authors:  R J Schiebinger; M Z Baker; J Linden
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

9.  Cardiovascular and hormonal responses to static handgrip in young and older healthy men.

Authors:  K Krzemiński; G Cybulski; A Ziemba; K Nazar
Journal:  Eur J Appl Physiol       Date:  2011-07-28       Impact factor: 3.078

10.  The effect of different anaesthetics on echocardiographic evaluation of diastolic dysfunction in a heart failure with preserved ejection fraction model.

Authors:  Ilona Cuijpers; Paolo Carai; Pedro Mendes-Ferreira; Steven J Simmonds; Paul Mulder; Daniela Miranda-Silva; Daria De Giorgio; Peter Pokreisz; Stephane Heymans; Elizabeth A V Jones
Journal:  Sci Rep       Date:  2020-09-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.